Caroline Loew is the founder of Glympse Bio. Glympse Bio has raised $69M in total funding. Latest round: Series B. Backed by Section 32, Temasek, DNS Capital.
Caroline Loew is the CEO of Glympse Bio, a biotechnology company that develops injectable biosensors to monitor disease progression and therapeutic efficacy. She became the company's leader shortly after its Series A funding round. Glympse Bio spun out of MIT.
Full founder directory · Investor directory · Company funding database · Fundraising library